메뉴 건너뛰기




Volumn 8, Issue 1, 2018, Pages

Discovery of a novel IL-15 based protein with improved developability and efficacy for cancer immunotherapy

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA;

EID: 85061662709     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-25987-4     Document Type: Article
Times cited : (36)

References (30)
  • 1
    • 0028179054 scopus 로고
    • Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor
    • COI: 1:CAS:528:DyaK2cXltVKht70%3D, PID: 8178155
    • Grabstein, K. H. et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264, 965–968 (1994).
    • (1994) Science , vol.264 , pp. 965-968
    • Grabstein, K.H.1
  • 2
    • 41149132993 scopus 로고    scopus 로고
    • Twelve immunotherapy drugs that could cure cancers
    • COI: 1:CAS:528:DC%2BD1cXlsFejtLo%3D, PID: 18364014
    • Cheever, M. A. Twelve immunotherapy drugs that could cure cancers. Immunological Reviews 222, 357–368 (2008).
    • (2008) Immunological Reviews , vol.222 , pp. 357-368
    • Cheever, M.A.1
  • 3
    • 0035102242 scopus 로고    scopus 로고
    • Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy
    • COI: 1:CAS:528:DC%2BD3MXivFOqur4%3D, PID: 11239443
    • Waldmann, T. A., Dubois, S. & Tagaya, Y. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 14, 105–10 (2001).
    • (2001) Immunity , vol.14 , pp. 105-110
    • Waldmann, T.A.1    Dubois, S.2    Tagaya, Y.3
  • 4
    • 33746547247 scopus 로고    scopus 로고
    • The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
    • COI: 1:CAS:528:DC%2BD28Xnt1yisb0%3D
    • Waldmann, T. A. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nature Review Immunology 6, 595–601 (2006).
    • (2006) Nature Review Immunology , vol.6 , pp. 595-601
    • Waldmann, T.A.1
  • 5
    • 0035399559 scopus 로고    scopus 로고
    • The Sushi domain of soluble IL-15 receptor alpha is essential for binding IL-15 and inhibiting inflammatory and allogenic responses in vitro and in vivo
    • COI: 1:CAS:528:DC%2BD3MXkslSqu74%3D
    • Wei, X. et al. The Sushi domain of soluble IL-15 receptor alpha is essential for binding IL-15 and inhibiting inflammatory and allogenic responses in vitro and in vivo. Journal of Immunology 167, 277–282 (2001).
    • (2001) Journal of Immunology , vol.167 , pp. 277-282
    • Wei, X.1
  • 7
    • 33750335080 scopus 로고    scopus 로고
    • Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo
    • COI: 1:CAS:528:DC%2BD28XhtFSns73O
    • Stoklasek, T. A., Schluns, K. S. & Lefrancois, L. Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo. Journal of Immunology 177, 6072–6080 (2006).
    • (2006) Journal of Immunology , vol.177 , pp. 6072-6080
    • Stoklasek, T.A.1    Schluns, K.S.2    Lefrancois, L.3
  • 8
    • 0034234925 scopus 로고    scopus 로고
    • Differences of biodistribution, pharmacokinetics, and tumor targeting between interleukins 2 and 15
    • COI: 1:CAS:528:DC%2BD3cXkvFChsbw%3D, PID: 10910071
    • Kobayashi, H., Carrasquillo, J. A., Paik, C. H., Waldmann, T. A. & Tagaya, Y. Differences of biodistribution, pharmacokinetics, and tumor targeting between interleukins 2 and 15. Cancer Research 60, 3577–3583 (2000).
    • (2000) Cancer Research , vol.60 , pp. 3577-3583
    • Kobayashi, H.1    Carrasquillo, J.A.2    Paik, C.H.3    Waldmann, T.A.4    Tagaya, Y.5
  • 9
    • 68549104128 scopus 로고    scopus 로고
    • E. coli expression and purification of human and cynomolgus IL-15
    • COI: 1:CAS:528:DC%2BD1MXhtVSmtrnE, PID: 19435602
    • Ward, A. et al. E. coli expression and purification of human and cynomolgus IL-15. Protein Expression and Purification 68, 42–48 (2009).
    • (2009) Protein Expression and Purification , vol.68 , pp. 42-48
    • Ward, A.1
  • 11
    • 33644975335 scopus 로고    scopus 로고
    • Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma. Hyperagonist IL-15 × IL-15R alpha fusion proteins
    • COI: 1:CAS:528:DC%2BD28XksFOlsA%3D%3D, PID: 16284400
    • Mortier, E. et al. Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma. Hyperagonist IL-15 × IL-15R alpha fusion proteins. Journal of Biological Chemistry 281, 1612–9 (2006).
    • (2006) Journal of Biological Chemistry , vol.281 , pp. 1612-1619
    • Mortier, E.1
  • 12
    • 42149162887 scopus 로고    scopus 로고
    • Preassociation of IL-15 with IL-15R alpha-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action
    • COI: 1:CAS:528:DC%2BD1cXhsVShtL4%3D
    • Dubois, S., Patel, H. J., Zhang, M., Waldmann, T. A. & Muller, J. R. Preassociation of IL-15 with IL-15R alpha-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action. Journal of Immunology 180, 2099–2106 (2008).
    • (2008) Journal of Immunology , vol.180 , pp. 2099-2106
    • Dubois, S.1    Patel, H.J.2    Zhang, M.3    Waldmann, T.A.4    Muller, J.R.5
  • 13
    • 37549007225 scopus 로고    scopus 로고
    • Crystal Structure of the interleukin-15.interleukin-15 receptor alpha complex: insights into trans and cis presentation
    • COI: 1:CAS:528:DC%2BD2sXhsVamurvL, PID: 17947230
    • Olsen, S. K. et al. Crystal Structure of the interleukin-15.interleukin-15 receptor alpha complex: insights into trans and cis presentation. Journal of Biological Chemistry 282, 37191–37204 (2007).
    • (2007) Journal of Biological Chemistry , vol.282 , pp. 37191-37204
    • Olsen, S.K.1
  • 15
    • 0024564552 scopus 로고
    • Control of enzyme activity by an engineered disulfide bond
    • Matsumara, M. & Mathews, B. W. Control of enzyme activity by an engineered disulfide bond. Science 243, 92–794 (1989).
    • (1989) Science , vol.243 , pp. 92-794
    • Matsumara, M.1    Mathews, B.W.2
  • 16
    • 0022998684 scopus 로고
    • In vivo formation and stability of engineered disulfide bonds in subtilisin
    • COI: 1:CAS:528:DyaL28Xit1Wgtrg%3D, PID: 3516996
    • Wells, J. A. & Powers, D. B. In vivo formation and stability of engineered disulfide bonds in subtilisin. Journal of Biological Chemistry 261, 6564–6570 (1986).
    • (1986) Journal of Biological Chemistry , vol.261 , pp. 6564-6570
    • Wells, J.A.1    Powers, D.B.2
  • 18
    • 0029766875 scopus 로고    scopus 로고
    • Engineering antibody Fv fragments for cancer detection and therapy: disulfide-stabilized Fv fragments
    • COI: 1:CAS:528:DyaK28XmtFagsr4%3D, PID: 9631086
    • Reiter, Y., Brinkmann, U., Lee, B. & Pastan, I. Engineering antibody Fv fragments for cancer detection and therapy: disulfide-stabilized Fv fragments. Nature Biotechnology 14, 1239–45 (1996).
    • (1996) Nature Biotechnology , vol.14 , pp. 1239-1245
    • Reiter, Y.1    Brinkmann, U.2    Lee, B.3    Pastan, I.4
  • 19
    • 84555186831 scopus 로고    scopus 로고
    • A recombinant immunotoxin engineered for increased stability by adding a disulfide bond has decreased immunogenicity
    • COI: 1:CAS:528:DC%2BC38XitFOjsLk%3D, PID: 22101015
    • Liu, W. et al. A recombinant immunotoxin engineered for increased stability by adding a disulfide bond has decreased immunogenicity. Protein Engineering, Design and Selection 25, 1–6 (2012).
    • (2012) Protein Engineering, Design and Selection , vol.25 , pp. 1-6
    • Liu, W.1
  • 20
    • 34548125264 scopus 로고    scopus 로고
    • Crystal structure of the IL-15-IL-15Ralpha complex, a cytokine-receptor unit presented in trans
    • COI: 1:CAS:528:DC%2BD2sXptlSkurs%3D, PID: 17643103
    • Chirifu, M. et al. Crystal structure of the IL-15-IL-15Ralpha complex, a cytokine-receptor unit presented in trans. Nature Immunology 8, 1001–1007 (2007).
    • (2007) Nature Immunology , vol.8 , pp. 1001-1007
    • Chirifu, M.1
  • 21
    • 67649843650 scopus 로고    scopus 로고
    • Strategies to extend plasma half-lives of recombinant antibodies
    • COI: 1:CAS:528:DC%2BD1MXovFSnsbs%3D, PID: 19489651
    • Kontermann, R. E. Strategies to extend plasma half-lives of recombinant antibodies. BioDrugs 23, 93–109 (2009).
    • (2009) BioDrugs , vol.23 , pp. 93-109
    • Kontermann, R.E.1
  • 23
    • 81455158710 scopus 로고    scopus 로고
    • IL-15:IL-15 receptor alpha superagonist complex: high-level co-expression in recombinant mammalian cells, purification and characterization
    • COI: 1:CAS:528:DC%2BC3MXhsFSktL%2FJ, PID: 22019703
    • Han, K. P. et al. IL-15:IL-15 receptor alpha superagonist complex: high-level co-expression in recombinant mammalian cells, purification and characterization. Cytokine 56, 804–10 (2011).
    • (2011) Cytokine , vol.56 , pp. 804-810
    • Han, K.P.1
  • 24
    • 84892407279 scopus 로고    scopus 로고
    • The IL-15-based superagonist ALT-803 promotes the antigen-independent conversion of memory CD8+T cells into innate-like effector cells with antitumor activity
    • PID: 24404427
    • Wong, H. C., Jeng, E. K. & Rhode, P. R. The IL-15-based superagonist ALT-803 promotes the antigen-independent conversion of memory CD8+T cells into innate-like effector cells with antitumor activity. Oncoimmunology 2, e26442 (2013).
    • (2013) Oncoimmunology , vol.2
    • Wong, H.C.1    Jeng, E.K.2    Rhode, P.R.3
  • 25
    • 85065766578 scopus 로고    scopus 로고
    • PCT International Application WO 2015103928 A1 20150716
    • Qu, X. et al. PCT International Application WO 2015103928 A1 20150716 (2015).
    • (2015)
    • Qu, X.1
  • 26
    • 85065787562 scopus 로고    scopus 로고
    • PCT International Application WO 2016095642 A1 20160623
    • Qu, X. et al. PCT International Application WO 2016095642 A1 20160623 (2016).
    • (2016)
    • Qu, X.1
  • 27
    • 70349482330 scopus 로고    scopus 로고
    • High antitumor activity of RLI, an interleukin-15 (IL-15)-IL-15 receptor alpha fusion protein, in metastatic melanoma and colorectal cancer
    • COI: 1:CAS:528:DC%2BD1MXhtFCis7jK, PID: 19723883
    • Bessard, A., Sole, V., Bouchaud, G., Quemener, A. & Jacques, Y. High antitumor activity of RLI, an interleukin-15 (IL-15)-IL-15 receptor alpha fusion protein, in metastatic melanoma and colorectal cancer. Molecular Cancer Therapeutics 8, 2736–2745 (2009).
    • (2009) Molecular Cancer Therapeutics , vol.8 , pp. 2736-2745
    • Bessard, A.1    Sole, V.2    Bouchaud, G.3    Quemener, A.4    Jacques, Y.5
  • 28
    • 84869410452 scopus 로고    scopus 로고
    • Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15
    • COI: 1:CAS:528:DC%2BC38XhsFOmtLbP, PID: 23104097
    • Ring, A. M. et al. Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15. Nature Immunology 13, 1187–1195 (2012).
    • (2012) Nature Immunology , vol.13 , pp. 1187-1195
    • Ring, A.M.1
  • 29
    • 0035423368 scopus 로고    scopus 로고
    • Cutting edge: the mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (alpha 2 integrin, very late antigen-2)
    • COI: 1:CAS:528:DC%2BD3MXls1WktLo%3D, PID: 11466327
    • Arase, H., Saito, T., Phillips, J. H. & Lanier, L. L. Cutting edge: the mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (alpha 2 integrin, very late antigen-2). J. Immunol. 167, 1141–1144 (2001).
    • (2001) J. Immunol. , vol.167 , pp. 1141-1144
    • Arase, H.1    Saito, T.2    Phillips, J.H.3    Lanier, L.L.4
  • 30
    • 84960166465 scopus 로고    scopus 로고
    • Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models
    • COI: 1:CAS:528:DC%2BC28XjvFansg%3D%3D, PID: 26511282
    • Rhode, P. et al. Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models. Cancer Immunology Research 4, 49–60 (2016).
    • (2016) Cancer Immunology Research , vol.4 , pp. 49-60
    • Rhode, P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.